This company listing is no longer active
Generex Biotechnology Beheer
Beheer criteriumcontroles 2/4
Belangrijke informatie
Joe Moscato
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 5.4yrs |
| Eigendom CEO | 0.4% |
| Management gemiddelde ambtstermijn | 5.4yrs |
| Gemiddelde ambtstermijn bestuur | 5.4yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Apr 30 2021 | n/a | n/a | -US$37m |
| Jan 31 2021 | n/a | n/a | -US$52m |
| Oct 31 2020 | n/a | n/a | -US$35m |
| Jul 31 2020 | US$623k | US$623k | -US$33m |
| Apr 30 2020 | n/a | n/a | -US$26m |
| Jan 31 2020 | n/a | n/a | -US$31m |
| Oct 31 2019 | n/a | n/a | -US$36m |
| Jul 31 2019 | US$103k | n/a | -US$9m |
| Apr 30 2019 | n/a | n/a | US$10m |
| Jan 31 2019 | n/a | n/a | US$24m |
| Oct 31 2018 | n/a | n/a | US$27m |
| Jul 31 2018 | US$100k | n/a | US$36m |
| Apr 30 2018 | n/a | n/a | US$9m |
| Jan 31 2018 | n/a | n/a | -US$37m |
| Oct 31 2017 | n/a | n/a | -US$43m |
| Jul 31 2017 | US$50k | n/a | -US$70m |
Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Joe redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de US markt.
Compensatie versus inkomsten: De vergoeding van Joe is gestegen terwijl het bedrijf verliesgevend is.
CEO
Joe Moscato (57 yo)
5.4yrs
Tenure
US$623,082
Compensatie
Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| CFO & Treasurer | 5.4yrs | US$10.00k | 0% $ 0 | |
| Chief Operating Officer | 4.4yrs | US$566.44k | 0% $ 0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Chief Legal Officer & Chief Administrative Officer | 2.8yrs | US$424.83k | 0% $ 0 | |
| Chief Commercial Officer | 3.4yrs | geen gegevens | 1.08% $ 658.9 | |
| Chief Scientific Officer & Chief Medical Officer | 5.4yrs | geen gegevens | 0% $ 0 | |
| Chief Marketing Officer | 3.6yrs | geen gegevens | geen gegevens | |
| Executive Vice President of Research & Drug Development | 5.4yrs | US$68.33k | 0% $ 0 |
5.4yrs
Gemiddelde duur
56.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van GNBT is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.4 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Independent Director | 18.3yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 5.4yrs | US$18.88k | 0.26% $ 160.2 | |
| Independent Director & Member of Scientific Advisory Board | 11.8yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 11yrs | US$118.33k | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | geen gegevens | geen gegevens | |
| Independent Director | 3.2yrs | geen gegevens | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.7yrs | geen gegevens | geen gegevens |
5.4yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van GNBT wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.4 jaar).